CH451126A - Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden - Google Patents

Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden

Info

Publication number
CH451126A
CH451126A CH76263A CH76263A CH451126A CH 451126 A CH451126 A CH 451126A CH 76263 A CH76263 A CH 76263A CH 76263 A CH76263 A CH 76263A CH 451126 A CH451126 A CH 451126A
Authority
CH
Switzerland
Prior art keywords
steroids
formyl
oxo
preparation
enol ethers
Prior art date
Application number
CH76263A
Other languages
English (en)
Inventor
Burn Derek
Ellis Bernard
Petrow Vladimir
Original Assignee
British Drug Houses Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Drug Houses Ltd filed Critical British Drug Houses Ltd
Publication of CH451126A publication Critical patent/CH451126A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Electric Cables (AREA)
  • Insulated Conductors (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH76263A 1962-01-26 1963-01-22 Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden CH451126A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3001/62A GB1005639A (en) 1962-01-26 1962-01-26 2(3)-unsaturated 3-enol ethers of 2-formyl-3-oxo-5ª‡-steroids and process for the preparation thereof

Publications (1)

Publication Number Publication Date
CH451126A true CH451126A (de) 1968-05-15

Family

ID=9750081

Family Applications (1)

Application Number Title Priority Date Filing Date
CH76263A CH451126A (de) 1962-01-26 1963-01-22 Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden

Country Status (8)

Country Link
US (2) US3160643A (de)
BR (1) BR6346445D0 (de)
CH (1) CH451126A (de)
DE (1) DE1443466A1 (de)
DK (2) DK107162C (de)
FR (2) FR1572954A (de)
GB (1) GB1005639A (de)
NO (1) NO123131B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415852A (en) * 1965-08-20 1968-12-10 American Cyanamid Co Method of preparing 3-alkoxy-2-formyl-delta2-steroids and new products resulting therefrom
US3562260A (en) * 1965-08-23 1971-02-09 Ormonoterapia Richter Spa 2-carbonyl-estratrienes and method of their preparation

Also Published As

Publication number Publication date
DE1443466A1 (de) 1969-01-30
NO123131B (de) 1971-10-04
DK109326C (da) 1968-04-16
BR6346445D0 (pt) 1973-07-03
DK107162C (da) 1967-05-01
US3160643A (en) 1964-12-08
FR1572107A (de) 1969-06-27
US3155692A (en) 1964-11-03
GB1005639A (en) 1965-09-22
FR1572954A (de) 1969-07-04

Similar Documents

Publication Publication Date Title
CH457490A (de) Verfahren zur Herstellung von N-Acylcysteinen
CH430677A (de) Verfahren zur Herstellung von p-Aminoarylaldehyden
CH464206A (de) Verfahren zur Herstellung von -Aminobenzylpenicillinen
CH435303A (de) Verfahren zur Herstellung von 2-Chlor-s-triazinen
CH451126A (de) Verfahren zur Herstellung von 3-Enoläthern von 2-Formyl-3-oxo-5a-steroiden
AT250582B (de) Verfahren zur Herstellung von 2-Oxa-3-oxo-steroiden
CH431511A (de) Verfahren zur Herstellung von 1a-Alkylthio-3-keto-steroiden
CH429729A (de) Verfahren zur Herstellung von Aminoisoxazolen
CH427812A (de) Verfahren zur Herstellung von Oxathiazolinonen
CH450405A (de) Verfahren zur Herstellung von 19-Hydroxy- 4-3-keto-steroiden
CH476707A (de) Verfahren zur Herstellung von 3-Enoläthern von 6-Formyl-3-oxo- 4-steroiden
AT241433B (de) Verfahren zur Herstellung von N-Trifluormethyl-N-aryl-aminosulfensäurehalogeniden
CH441349A (de) Verfahren zur Herstellung von s-Tetrazinen
CH440265A (de) Verfahren zur Herstellung von 19-Norsteroiden
CH443283A (de) Verfahren zur Herstellung von 3-Methylen-steroidenn
CH431518A (de) Verfahren zur Herstellung von 16B-Niederalkylthio-17B-hydroxy-östren-3-onen
AT257064B (de) Verfahren zur Herstellung von 16α-Hydroxysteroiden
AT242149B (de) Verfahren zur Herstellung von 2-Sulfanilamido-5-methoxypyrimidin
CH431510A (de) Verfahren zur Herstellung von Diacylcymarol
CH409978A (de) Verfahren zur Herstellung von 1-Aryl-hydropyrazolen
CH435302A (de) Verfahren zur Herstellung von 3-Alkoxy-4-nitro-6-alkylpyridazin-1-oxyden
CH430735A (de) Verfahren zur Herstellung von 2-Hydroxy-s-triazinen
CH428750A (de) Verfahren zur Herstellung von N-Trifluormethylaminen
CH478110A (de) Verfahren zur Herstellung von 5a- 1-Androstenolen
CH441298A (de) Verfahren zur Herstellung von 8B-Methyl-11B-oxysteroiden